Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-06T16:00:52.818Z Has data issue: false hasContentIssue false

Cephazolin and metronidazole prophylaxis in head and neck surgery

Published online by Cambridge University Press:  29 June 2007

Melvin Strauss*
Affiliation:
Department of Otolaryngology–Head and Neck Surgery Case Western Reserve University School of Medicine, Cleveland, Ohio.
Phillip W. Saccogna
Affiliation:
Department of Easley Head and Neck Surgery, Easley, South Carolina.
Allan L. Allphin
Affiliation:
Department of Regional ENT Center, Springfield, USA.
*
Adress for correspondence: Melvin Strauss, M.D., University Hospitals of Cleveland, 2074 Abington Road, Cleveland, Ohio, 44106, USA.

Abstract

A seven-day course of cephazolin and metronidazole chemoprophylaxis for clean-contaminated head and neck oncological procedures is compared to results with previously published antibiotic regimens. Aetiological factors associated with increased rates of wound complications are analyzed. Retrospective analysis of procedures over asix-year period was performed. The overall wound complication rate was 28.1 per cent, comparing favourably with previously published results. A major fistula was the most common complication with a rate of 9.2 per cent. Factors statistically associated with increased rates of wound complications included: radical neck dissection, extended surgical procedures requiring flap reconstruction, previous tracheotomy, and race. This is the largest single institutional study to show thata seven-day course of cephazolin and metronidazole is an effective chemoprophylactic regimen in head and neck surgery.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable